# Surgical Theater

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/surgical-theater

- Industry: Software
- Headquarters: Cleveland, US
- Website: www.surgicaltheater.net
- Total disclosed funding: $9M
- Latest round: Series A (Oct 19, 2015)
- Investors on record: 2

## About

Surgical Theater develops eXperiential Reality (XR) solutions that enhance surgical precision and patient engagement. Their advanced visualization technology aids in the meticulous planning and execution of surgical procedures.Surgical Theater, founded in 2010, is based in Cleveland, US, and specializes in XR solutions for surgical environments. The company raised USD 9.00 mn in Series A funding in October 2015, led by HTC Corporation and Shanghai Creation Investment Management Co. The firm has successfully closed 2 deals to date. Founders Alon Geri and Moty Avisar have been instrumental in establishing the company’s mission to improve surgical outcomes through innovative technology.Surgical Theater specializes in eXperiential Reality (XR) solutions that enhance surgical precision and patient engagement through advanced visualization technology. Their flagship offerings include patient-specific XR reconstructions that allow surgeons to meticulously plan and rehearse surgical procedures in a virtual environment, significantly improving surgical outcomes. The XR Studio™ platform serves as a multi-user environment where medical professionals can engage in dynamic case reviews and educational presentations while utilizing XR headsets. These products aim to streamline the surgical process, particularly in specialized fields such as epilepsy care, by presenting complex patient data in an easily digestible XR format. Surgical Theater primarily targets healthcare providers, including hospitals and surgical centers, across geographic markets such as the United States, Europe, and select regions in Asia, directly benefiting surgeons, medical institutions, and patients alike.Surgical Theater's revenue model is centered around a combination of business-to-business transactions, primarily through partnerships and direct sales to healthcare institutions. The company offers subscription-based access to its XR Studio™ platform, which provides ongoing updates and support for users. Additionally, Surgical Theater engages in direct sales of its XR visualization tools, including immersive models tailored for individual patients, enhancing both the surgical planning and patient education processes. While specific pricing details for individual products and services are not disclosed, the structure typically involves long-term contracts with healthcare providers who integrate these technologies into their surgical workflows. This transactional framework fosters a collaborative relationship between Surgical Theater and its clients, aiming for improved surgical outcomes and enhanced patient experiences.Moving forward, Surgical Theater plans to leverage its recent funding of USD 9.00 mn from the Series A round to further develop its XR products and expand its market reach. The company is focused on enhancing its XR Studio™ platform with new features aimed at improving usability and integrating additional functionalities for surgical teams. In addition to product development, Surgical Theater is targeting expansion into new geographic regions, specifically increasing its presence in Europe and Asia by 2025, aiming to establish partnerships with healthcare providers in those areas. This strategic approach is designed to enhance the influence of Surgical Theater's innovative solutions on a global scale.

## Funding rounds

- Series A, Oct 19, 2015, $9M — HTC Corporation, Shanghai Creation Investment

## Investors

- HTC Corporation — Series A
- Shanghai Creation Investment (https://capitalatlas.ai/funds/shanghai-creation-investment) — Series A